SG Americas Securities, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$485
-37.7%
4,761
-44.4%
0.00%
-55.6%
Q1 2023$778
+194.7%
8,558
+23.1%
0.01%
+200.0%
Q4 2022$264
-99.9%
6,952
-13.8%
0.00%0.0%
Q3 2022$203,000
-25.6%
8,067
-10.1%
0.00%0.0%
Q2 2022$273,000
+108.4%
8,976
+80.2%
0.00%
+200.0%
Q4 2021$131,000
-90.4%
4,981
-63.3%
0.00%
-83.3%
Q3 2021$1,364,000
+171.7%
13,561
+282.4%
0.01%
+200.0%
Q2 2021$502,000
+160.1%
3,546
+83.6%
0.00%
+100.0%
Q1 2021$193,000
-85.5%
1,931
-82.0%
0.00%
-85.7%
Q4 2020$1,327,000
+57.0%
10,736
+23.8%
0.01%
+40.0%
Q3 2020$845,000
+46.2%
8,675
+134.2%
0.01%0.0%
Q2 2020$578,000
-30.4%
3,704
-35.6%
0.01%
-37.5%
Q1 2020$830,000
+49.5%
5,750
+111.7%
0.01%
+60.0%
Q4 2019$555,000
+130.3%
2,716
+6.4%
0.01%
+150.0%
Q2 2019$241,000
-4.0%
2,553
-13.0%
0.00%0.0%
Q1 2019$251,000
+46.8%
2,936
-4.0%
0.00%
+100.0%
Q4 2018$171,0003,0570.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders